Back to Journals » OncoTargets and Therapy » Volume 15

Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 [Corrigendum]

Authors Wang J , Li H, Xia C, Yang X, Dai B, Tao K, Dou K

Received 4 October 2022

Accepted for publication 4 October 2022

Published 10 October 2022 Volume 2022:15 Pages 1143—1145

DOI https://doi.org/10.2147/OTT.S392180



Wang J, Li H, Xia C, et al. Onco Targets Ther. 2019;12:869–882.

The authors have advised Figure 2E on page 874 is incorrect. Due to an error at the time of figure assembly NC (24 h) and shCENPK (48 h) in the SMMC-7721 row were inadvertently duplicated. The correct Figure 2 is as follows.

Figure 2 Silencing of CENPK inhibits HCC cell growth, migration, and invasion in vitro.

Abbreviations: qRT-PCR, quantitative real-time PCR; CCK-8, Cell Counting Kit-8; NC, negative control.

Notes: (A) Expression of CENPK in BEL-7404 and SMMC-7721 cells was confirmed by qRT-PCR and Western blotting after transfection with shCENPK lentivirus or shNC. (B) Proliferation rate of BEL-7404 and SMMC-7721 cells was measured over 4 days by the CCK-8 assay. (C and D) Representative images (C) and quantification (D) of the colony formation assays are shown for BEL-7404 and SMMC-7721 cells. (E) Analysis of migration in BEL-7404 and SMMC-7721 cells as measured by wound healing assays (×200). (F and G) Analysis of invasion in BEL-7404 and SMMC-7721 cells as measured by transwell assays. (F) Representative photographs (×200). (G) Number of invaded cells was counted in five randomly selected areas. Scale bar =100 μm. NC represents negative control group (shNC), and shCENPK represents downregulation of CENPK group. *P<0.05, **P<0.01, ***P<0.001.

The authors apologize for this error and advise it does not affect the results of the paper.


Read the original article


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.